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Including Organizational Ethics in Policy Review Processes in Healthcare 
Institutions: A View from Canada 
 
Fiona McDonald1, Dr. Christy Simpson2, Fran O’Brien3  
 
 
Whilst clinical ethics processes are an increasingly accepted part of institutional culture in 
healthcare, broadening the focus of these processes to include the organization as an 
ethical actor (organizational ethics) remains a work in progress.  Drawing from our 
experiences as members of the Ethics Committee at the IWK Health Centre in Canada, 
(the IWK) in this paper we focus on our experiences of moving organizational ethics 
from “theory to practice”.  We particularly address the operational and functional 
challenges associated with this transition in regard to the ethics committee’s role in policy 
development and review.      Even in a health centre with a relatively strong commitment 
to ethics and ethical practice, the inclusion of an organizational ethics perspective has 
raised new questions and challenges. 
 
Introduction to Organizational Ethics 
 
Organizational ethics is a new field of inquiry in bioethics (Kenny, Downie, Ells & 
MacDonald, 2000). It stems from a recognition that, to quote Emmanuel, “moral 
demands exist not only on the individual but also on organizations, systems and 
institutions” (2000, p. 151).   Reiser notes “health care organizations … must recognize 
that the existence of ethical dialogue in one of its parts is insufficient to give the whole 
organization an ethical identity” (1994, p. 29).  Or, as Wolpe concisely summarises it, 
what is needed is an ethics of the system, rather than in the system (2000).  What this 
means is that it is not enough for an organization to claim that it is an ethical actor by 
having committees or boards that separately address clinical and/or research ethics – 
more is required.  Organizational ethics intends to contribute to the development of 
ethical healthcare organizations, in part, by clarifying the values at stake in all decisions 
and practices within these institutions, not just those relating to research or clinical 
practice (Kenny, Downie, Ells & MacDonald, 2000).  Organizational ethics therefore 
provides a framework for ethical discourse across all aspects of the organization and 
creates a framework through which an institution can recognise the relational nature of 
its being; its impact, positively and negatively, on others (Magill & Prybil, 2004).  As 
Kenny and Giacomini note: “The scope of concern reaches beyond specific individuals 
and relationships to consider populations, groups, institutions and communities” – 
internal and external to the organization. (2005, p. 251)  In summary, organizational 
ethics is about conceptualising the organization as an ethical actor. 
 
Organizational Ethics at the IWK Health Centre 
The IWK Health Centre is a tertiary hospital facility that provides health services 
to women, youth and children from (primarily) three Canadian provinces: Nova Scotia; 
New Brunswick; and Prince Edward Island. The IWK is also a teaching hospital, with 
affiliations with Dalhousie University and other academic teaching institutions, and is 
committed to leadership in research, particularly in respect of children’s health. 
In the early 2000’s the IWK Health Centre reviewed its non-research related 
ethics processes and procedures, in collaboration with the Department of Bioethics at 
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Dalhousie University.  With leadership from the Department of Bioethics, the decision 
was made to develop a separate clinical ethics consultation service and to reconstitute the 
ethics committee with a focus on organizational, rather than solely clinical, ethics.  The 
operations of the clinical ethics consultation service are, at least nominally, overseen by 
the ethics committee.  The coordinator of the clinical ethics consultation service provides 
quarterly updates to the ethics committee, and some members of the ethics committee 
are also clinical ethics consultants at the IWK.   
The reconstituted ethics committee, established in mid-2003, has a dual reporting 
relationship to the Chief Executive Officer (CEO) and President of the IWK Health 
Centre and the IWK Board of Directors.  This high-level reporting relationship is 
important as organizational ethics addresses issues that potentially have implications for 
the management practices and functioning of the organization and which accordingly 
may need to be addressed at the highest levels of management.  The dual reporting 
relationship also ensures that, for example, if a critique of the decision(s) made by 
President/CEO is required the committee has another reporting option and some 
assurance of independence.   
The ethics committee has representation from various areas (clinical, 
administrative and other such as patient advocacy and spiritual care) within the IWK and 
external members drawn from consumers and the community (especially from 
traditionally disadvantaged sections of the community, such as African Nova Scotians) or 
who have specialist skills (bioethics and health law).  In recognition of the fact that 
specific issues may require specialised skills or expertise, the committee may, on an ad 
hoc basis, invite additional persons into the process, if their knowledge or skills are 
required to address the issue.  This might include, for example, expertise in business 
ethics.   The broadly constituted membership is important to ensure a plurality of 
perspectives but also ensures a degree of independence in perspective and facilitates the 
ability to challenge organizational cultural norms and practices.  For the latter reason, 
amongst other considerations, no person in a senior management role may be a member 
of the ethics committee. 
The functions of the ethics committee remain similar to those of a traditional 
ethics committee with a clinical focus: education; consultation; and policy review (Doyal, 
2001; Kirby, Simpson, McNally & McDonald, 2005).   Education is conducted within the 
committee, within the institution and ideally also in the community.  As discussed above, 
ethical issues arising from the care and treatment associated with a specific patient are the 
responsibility of the clinical ethics consultation service.  This does not mean that the 
ethics committee no longer has a role in consultation – however the ethics committee, 
instead, undertakes organizational ethics consultations (Kirby, Simpson, McNally & 
McDonald, 2005).   The primary focus of this paper is the ethics committee’s role in 
reviewing organizational policies with significant ethical implications and in bringing an 
organizational ethics lens to the IWK’s policies and policy processes overall.  These are 
policies across the broad spectrum of organizational enterprises – in other words the 
ethics committee may review clinical and non-clinical policies.  The IWK’s process for 
developing, reviewing and approving clinical policies was well developed and transparent 
when the newly constituted ethics committee began its operations.  There was no such 
clearly defined process for non-clinical policies.  Accordingly, initially, policies that were 
sent to the ethics committee for review were overwhelmingly clinical in nature, at least 
until an increased understanding and awareness of the organizational ethics approach, as 
well as advocacy from key parties (discussed further below) saw policy-makers sending a 
broader range of policies for organizational ethics review by the ethics committee.     
It is important to emphasise that the ethics committee’s role is advisory – its role 
is not to approve policy or practice in any formal sense, but rather to make 
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recommendations about and alert policy-makers to the underlying normative issues 
contained within their decisions, policies, or practices so that they may make choices 
about the values that the institution expresses and instantiates in organizational practice.   
 
Challenges Faced by the Ethics Committee 
 
It is fair to state that, for the most part, few members of the management team at the 
IWK and few of the newly recruited members of the ethics committee (the latter despite 
a comprehensive orientation delivered by the Department of Bioethics at Dalhousie 
University) had conceptualised the scope or implications of organizational ethics as the 
new ethics committee got off the ground. This meant that the ethics committee 
experienced some operational challenges in its first few years as this was worked out, 
challenges that impacted upon its ability to review appropriate policies as well as to 
function more generally.  These respective challenges are outlined in the paragraphs that 
follow.     
In our experience operational challenges can be loosely categorised as being 
attitudinal or systemic, although we acknowledge that there is some overlap between 
these categories.  By ‘attitudinal’ we refer to the attitudes of individuals and systems 
about the value of organizational ethics review and a lack of knowledge and/or 
awareness of the contribution that this type of review may make to the functions and 
functioning of an organization.  By ‘systemic’ we refer to systems in place within the 
organization/institution that impact upon the ability of the ethics committee to 
contribute to policy development and review.   
 
Attitudinal Challenges  
 
The ethics committee faced three key attitudinal challenges: 1) a perception that non-
clinical matters did not have ethical implications and were in fact morally neutral 2) 
resistance to the idea that high-level managerial decisions instantiated in policy could and 
should be subject to review from within the organization and 3) a perception, commonly 
experienced by many ethics committees, that the review of policy from an ethical 
perspective is or should be pro forma at best.  
Whilst there was broad acceptance that clinical policies had an ethical dimension, 
at least insofar as policies related to the relationship between health professional and 
patient, there was a general perception that non-clinical policies did not have ethical 
implications and were in fact morally neutral.  According to Mason et al., policy often 
“encompasses the choices that a society, segment of society, or organization makes 
regarding its goals and priorities and the ways it will allocate its resources” – processes 
and choices with inherent moral implications (2002, p. 8)  Malone further suggests that 
policies, insofar as they involve decisions about how to act towards individuals (and 
groups) who we do not know and who are not directly involved in deciding what to do 
about a specific problem, will often have a moral dimension (1999).    Those then who 
make policy must, to quote Malone, be regarded as “agents who are involved in making 
or shaping moral choices on behalf of the larger society” (1999, p. 16).  Whilst some 
types of policies may by their nature have a lesser moral dimension than others, no policy 
is completely morally neutral, regardless of the ends to which it is used or applies.  
Initially it was difficult for some policy-makers to accept this approach to policy 
development and review at the IWK.  It was especially difficult when the decisions were 
perceived as being high level strategic decisions.   
In addition, it was also difficult for policy and decision-makers, especially those 
involved in clinical policies, to look beyond the relationship between health professional 
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and patient to consider the relationship between patient and institution, staff and 
institution, and community and institution as part of policy development.  These latter 
relationships for the most part do not tend to be framed in discourse as relationships that 
have an ethical dimension – rather the decisions, policies, and practices that impact upon 
these relationships are often characterised as management, human resource, or public 
relations issues and thus as being ethically neutral.  When the complexities of these 
broader relationships were captured, or at least alluded to, in clinical policies the issues 
were under-developed and were not addressed consistently.   This was the gap that the 
work of the ethics committee helped to illustrate and provided some guidance to policy-
makers as to how to address it.      
At the attitudinal level, many ethics committees struggle with an embedded 
institutional perspective that the process for ethical review of policy is pro forma at best.  
Many ethics committees report that there is an expectation that ethics committees will 
rubber-stamp policies or are placed in a position where to provide critical feedback 
would be seen as creating an obstacle in the way of efficient institutional processes.  It 
could be that policy-makers genuinely thought that after some years of awareness of 
ethical issues they were well able to identify and address ethical issues during the process 
policy formulation or that the policy was ethically neutral.  Even though institutional 
policies that related to clinical issues had long been subject to ethical review at the IWK 
and the desirability of ethics review for this sub-set of policies was generally accepted, the 
ethics committee at the IWK was confronted with these types of attitudes.  In these 
circumstances there was surprise and dismay when the ethics committee responded with 
serious concerns about the values implicit in the policies.   
Once we had identified these attitudinal challenges the ethics committee 
developed three primary strategies to help address them: targeted education; other 
proactive initiatives; and leveraging accreditation requirements.  These strategies also 
increased the profile of the ethics committee more generally.   
 
Targeted Education 
The ethics committee determined that targeted education was required of certain key 
actors in the policy-making process to raise awareness of the importance of 
organizational ethics and the contribution that could be made by the ethics committee to 
organizational functioning.  At a pragmatic level we also wanted to ensure that policies 
that raised significant ethical issues were directed to the ethics committee for ethics 
review and that all actors within the IWK realised that they could access the ethics 
committee in respect of issues raising ethical concerns that related to organizational 
policies or practices.  The ethics committee identified key actors and subsequently 
delivered targeted educational sessions about the role of the ethics committee and its 
functions.   
One initial target was the President/CEO with whom the chair of the ethics 
committee and the bioethics representative met reasonably regularly early in the 
committee’s development and activities.  These meetings alerted the President/CEO to 
the challenges and questions being raised by the organizational ethics perspective and 
sought her ongoing endorsement of the ethics committee’s efforts.  It also enabled the 
committee to seek direction as to certain key issues in respect of the committee’s 
functions and approach. Efforts have also been made to provide information about the 
role and functions of the ethics committee to members of the Board of Directors, 
primarily through orientation materials, although educational sessions are planned.  
Senior leadership team meetings were also targeted and presentations made to this group 
about the role and functions of the ethics committee.  These efforts have been successful 
in raising the profile of the ethics committee and its work at the highest level and 
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encouraging high-level decision-makers to ask whether the policy has been subject to 
ethics review where appropriate.    
Another initial target for direct education was the clinical policy coordinator who 
shepherds clinical policies through the development, review and approval processes.  We 
convened a meeting with the coordinator to discuss the purpose and importance of 
ethical policy review and the criteria which indicated policies that should be directed for 
ethical review.  This served two purposes.  First, it enabled us to remind the coordinator 
of the committee’s broader remit for reviewing policy and the criteria for referral, the 
result of which was that some clinical policies not previously referred for review were 
sent to the ethics committee.  Second, as the only coordinator of policy at the IWK, the 
clinical policy coordinator was often aware of or was asked to assist with the 
development of non-clinical as well as clinical policies within the IWK.  Thus in the 
absence of a defined process for the formulation and approval of non-clinical policies 
and an non-clinical policy coordinator the clinical policy coordinator was able to raise 
awareness of the ethics committee as a resource and a stakeholder for review for non-
clinical policies.           
There were a number of other individuals and groups that we subsequently 
targeted for education.  The Quality Resources and Decision Support Services group 
(which includes the IWK’s legal counsel) were one such group, as members of this team 
frequently participate in or lead policy working groups and review most, if not all, 
policies.  It became apparent that there was a lack of clarity as to the differences between 
a review of a policy from a risk management/legal perspective and from an ethical 
perspective.  After some joint discussions we distinguished the legal/risk role from the 
ethics role in policy development and review and agreed to refer policies or concerns 
about policies appropriately.  Also we agreed that, as a way to help increase 
understanding and communication, we should ask the President/CEO to approve the 
addition of a member of the Quality Resources and Decision Support Services Group to 
the Committee (a request that was subsequently approved).4  Other groups targeted with 
formal education sessions included: the programs operations committees (Paediatrics, 
Women and Newborn, and Mental Health); the Nursing Professional Practice Council; 
Mortality and Morbidity meetings; and the Clinical Managers. 
 
Proactive Initiatives 
We adopted three primary pro-active initiatives in respect of raising the profile of the 
ethics committee in respect of policy reviews:5 indirect education, follow-up of 
organizational ethics consultations; and pro-active reviews of selected organizational 
policies.  Indirect education involved ethics committee members acting as ambassadors 
for the role, purpose, and function of the committee.  Indirect education was and is also 
provided informally by members of the ethics committee in the context of their other 
professional or administrative responsibilities.  Thus, for example, the nursing 
representative(s) reference the work of the ethics committee in the context of 
deliberations of the Nursing Professional Practice Council about policies.  Members of 
the ethics committee who are members of policy working groups or work with those 
who are members of working groups educate those groups/individuals about the 
role/purpose of ethics review.  This informal educative method is very valuable in raising 
the profile of the ethics committee and in ensuring that policies for which ethics review 
is appropriate and desirable are referred for review, e.g., human resources policies. 
                                                 
4 The member from the Quality Resources and Decision Support Services Group was not to be from the 
legal services team to preserve the distinction between legal review and ethical review. 
5 This was in addition to other initiatives that raised the profile of the ethics committee more generally in 
respect of all its functions, such as a page on the IWK’s intranet.   
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Organizational ethics consultations are both a reactive and proactive mechanism.  
Individuals or groups can react against a decision or policy by asking the ethics 
committee to review the ethical implications of the decision or policy.  The 
policy/practice/decision may impact upon the interests of an individual in a non-clinical 
context (e.g. an individual staff member) or on a group in clinical or non-clinical contexts 
(e.g. groups of patients, health providers, the community or other affected parties).  
Proactively, the institution or institutional actors may seek advice from the ethics 
committee in respect of difficult and ethically complex issues upon which a decision 
must be made.   Organizational ethics consultation is an important part of the ethics 
committee’s functions and makes an important contribution, in our opinion, to 
organizational culture and thus to the development of the organization as an ethical 
actor.  Organizational ethics consultations resulted in the identification of gaps in 
institutional policies and practices, for example, the lack of a conflict of interest policy.  
These gaps needed to be filled by the development of new policies or the review of 
existing policies.  Reporting processes whereby the President/CEO received copies of 
the outcomes of organizational ethics consultations brought these issues high-level 
attention.  Whilst it is not the role of the ethics committee to draft policies, these 
consultations enabled reflection on the issues and a clarification of the ethical questions 
that underlay the issue(s).  This provided valuable guidance for policy-makers 
subsequently engaged in the delicate process of balancing divergent needs whilst 
formulating institutional policy.   
To further reinforce the contribution to the development and expression of 
organizational values and mission that ethics can make, the ethics committee reviewed 
the latest iteration of the IWK’s core values, mission and vision and key strategic 
directions and provided feedback to the President/CEO. 
  
Accreditation 
The accreditation process through the Canadian Council on Health Services 
Accreditation accords some centrality to ethics at the clinical level and the governance 
level.  This self-assessment and inspection process aims to improve the quality of all 
aspects of care and services in health facilities, including ethical leadership; i.e., does the 
organization live its values and empowers patients and families? The introduction of 
accreditation and accreditation processes have been associated in a number of 
jurisdictions with organizational change and development and to quote Pomey et al. can 
also be “considered as an agent of change affecting all areas of the organization and all 
actors” (2004, p.114). The ethics committee leveraged the accreditation process in two 
ways: to remind managers of the presence, purpose and function of the ethics committee 
and its importance vis-à-vis accreditation and in the development of institutional culture, 
and to remind organizational groups of its presence, purpose, and function as a resource 
to support the development of ethics and the development of policies which accorded 
recognition and respect of ethical values in those areas.   
 
Systemic Challenges 
 
At the systemic level, existing processes within the IWK in regards to policy 
development and review posed a challenge for the ethics committee.  As discussed 
earlier, while there was a formal structure within the IWK with regards to the 
development, review and approval of clinical policies, there was no formal structure for 
other types of policies.   
 Even when there is a formal structure, as in the case for clinical policy, the 
process for clinical policy development may be silent or unclear about ethics review, 
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which may contribute to policy-making bodies not inviting ethical review of policies 
(Ells, 2006).  Although the IWK’s clinical policy/objective manual recognized the 
existence of the ethics committee as one of a number of bodies which could be asked 
to review a policy, the consultation flow chart did not explicitly refer to the ethics 
committee.  In addition, no information was provided in the manual about what type 
of review was provided by the ethics committee and what types of policies should be 
provided to the ethics committee for review.  Accordingly, the ethics committee 
liaised with the clinical policy coordinator and the clinical policy manual and flow 
chart were reviewed and revised.  The ethics committee now appears at the beginning 
of the process as a resource that can be consulted with in the early stages of policy 
development and review.  The ethics committee also appears as a special reader to 
which policies could be sent to for ethics review prior to final approval, where this is 
appropriate.  The clinical policy manual also provides further information about the 
ethics committee, its role and processes, and guidelines/criteria as to when the policy 
should be sent to the ethics committee for review.  It states that policies with 
“significant ethical dimensions must be reviewed by the IWK Ethics Committee.”  An 
indicative, but not exhaustive, list of issues that have significant ethical dimensions is 
provided to further illustrate meaning.   
The ethics committee considered the lack of a set process for the development 
and approval of non-clinical policies a problem.  The lack of a policy development and 
approval framework constituted an organizational ethics issue in and of itself.  Important 
ethical values for an organization, in this respect, are transparency, consistency, 
accountability and contestability/natural justice.  The processes for non-clinical policy 
approval were not transparent nor were they consistent.  Groups with an interest in 
contesting the directionality of those policies may not have been accorded the 
opportunity to do so when there is no set process.  Thus having a policy approval 
framework for clinical policies (in some senses) only privileged the interests of patients 
above the interests of other affected groups or individuals (most pertinently perhaps 
those who work in the institution).  A lack of a policy approval framework also meant 
that policies with significant ethical content but which were not clinical in nature would 
not necessarily be directed towards ethical review.  The ethics committee approached the 
President and CEO with our concerns about the difficulties this lack of process both 
created and contributed to.  Subsequently, the chair of the ethics committee and the 
bioethics representative met with members of the Quality Resources and Decision 
Support Services Group, as part of the development of a process for non-clinical policies 
– a process that per its terms of reference will not be silent as to the importance of ethical 
review.   Currently, we are awaiting further direction from senior leadership as to when 
this process can be implemented.   
Overall we believe that we have made some important first steps, but much 
remains to be done as operational challenges are not subject to a quick fix but remain on-
going challenges on which the ethics committee continues to focus its attention.  
Changing attitudes is always difficult.  From our perspective support from key 
institutional leaders has been the most successful and important factor in changing 
attitudes.  When key senior leadership groups pronounced themselves unwilling to 
review policies of significant ethical import that had not been previously reviewed by the 
ethics committee (usually groups with representatives who also sat on the ethics 
committee), and, most particularly, that the ultimate decision-makers in the institution 
were not going to approve them (led by the President/CEO), we saw a sea-change in 
attitudes.     
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Organizational Ethics Review of Policies 
 
This section focuses on what the ethics committee does with policies when they arrive 
for review.  The first step is to review the policy and the second to provide feedback to 
policy-writers.   
 
Principles Underlying Organizational Ethics Review of Policies 
 
Obviously it is important that the ethics committee take a distinctly ethical approach in 
its review (Ells, 2006) and, in the case of the IWK Ethics Committee, an organizational 
ethics approach.   
To this end, the ethics committee is clear that policies must be reviewed with the 
interests of all those who may be potentially affected by the policy in mind or, in other 
words, it must take a relational approach to its analysis.  First, the policies always affect 
the IWK as they both help establish and instantiate the values of the institution and its 
culture.  Second, IWK’s policies affect those who receive treatment and care at the IWK, 
and, as the IWK provides family focused care, their families and friends.  Third, policies 
affect those who work, train, as the IWK is a teaching hospital, or volunteer at the IWK.  
As Wolpe notes “the influence of organizations on those who labor within is profound” 
(2000).  Wall notes that 
the way in which an organization treats the people who carry out its purpose 
impacts both the functioning and success of the organization but also the health 
and well-being of its human resources … Employees or contracted professionals 
… have a right not to be treated as a means to some end (2007, p.229).   
Fourth, policies may affect other health providers in the region, for example, by shifting 
a burden of care onto another health provider or institution.  Fifth, policies may affect 
the community in a number of ways.  One example may be a no-smoking rule for the 
IWK may mean that patients, staff and visitors crowd the pavements in front of the 
facility to smoke.  Other examples could be when a decision is made to cease to offer 
health services in a particular area. Sixth, the policies of the IWK may affect social 
services (government and non-governmental) such as child protection agencies, the 
police and so on.    
Policy-makers must have regard to and balance, where relevant, these interests 
when creating policies – in addition to including and balancing the relevant values and 
principles at play.  However, policy-makers are not necessarily cognisant of these 
interests when formulating policy and it is an important role of the ethics committee 
when reviewing policy to remind policy-makers, where relevant, to consider interests 
more comprehensively.  In addition, it is also part of the ethics committee’s role to 
emphasise that where there are a multiplicity of affected parties all of whom function 
collectively in a community of interest there will often be competing interests and 
obligations and a need for balance.  As Kenny and Giacomini put it: 
When many people – as well as societal constructs such as institutions and 
economies – are affected in many ways by every decision, the moral quandaries 
arise not in the question of whether to harm or benefit but how to harm and benefit: 
whom, how much, how certainly, in what ways, and so forth (2005, p. 254, 
original emphasis) 
To assist with the policy review process the committee has formulated a list of 
questions that it uses to guide its review of policies.  These are trigger questions designed 
to help the committee members think more broadly about the different ethics aspects of 
policies.  It is not expected that all questions would apply to all policies or that these are 
the only questions that could be asked about the policy from an ethical perspective.  
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These questions include: What are the values (explicit or implicit) at issue in the policy?  
Are these values clearly articulated or should they be? Are the values congruent with 
Health Centre values? What are the relevant ethical principles or theories operating in 
this situation? What is the potential “good” or the potential “harm” inherent in this 
policy (including the potential for moral distress)? Does the policy restrict or limit 
treatment options? Does the policy treat all who are affected by it equally? Does the 
policy result in overriding the patient’s or surrogate’s wishes? Does the policy result in a 
restriction of liberty? Does the policy allow for disclosure of information when that 
person, or group of persons, might not consent to the disclosure? Does the policy impact 
on privacy?  Does the policy impact upon the exercise of autonomy? Does the policy 
impact on vulnerable groups (internal or external)? Does the policy impact the civil rights 
of anyone in the Health Centre (including rights to natural justice)?  Does the policy 
impact upon the community?  Were vulnerable people given voice? Does the policy 
expect too much or too little from those expected to uphold it?  Is the language used 
appropriate (for example is it family centred, culturally sensitive)?  Is this a policy the 
Health Centre would be comfortable having the public know about?  
The ethics committee believes that the IWK’s ethical responsibilities to policy 
users require that if and when it sets out policy parameters within which users must act 
then it has an ethical obligation to ensure that such guidance is clear and readily 
understandable by its users.  In addition, in our opinion, an ethical institution is one that 
is reflective about its practices, so policies and procedures must contain mechanisms that 
enable such reflection, for example quality assurance, reporting and review and 
complaints mechanisms.  So, in our view, an ethical review encompasses reviewing 
whether the policy is or will be effective.  Questions that we ask when conducting an 
effectiveness review include: Are the policy statement and procedures clear? Are key 
terms defined? Were the “right people” (those who might be impacted, those who have 
to apply the protocol or guidelines, etc.) included in the process of policy development?  
Do the provisions of this policy conflict with the provision of other existing or 
anticipated organizational policies?  Is there a process for “enforcing” the policy or 
ensuring the policy will be upheld?  Is there a process for ensuring the goals of the policy 
are achieved?  Are there quality assurance processes within the policy?  Are there specific 
issues relating to the IWK’s ethical obligations to users in respect of the implementation 
of the policy? 
It is also an important part of the process to recognise that words carry meaning 
and thus the words used in the policy carry moral and ethical implications.  To quote 
Malone: 
If, as Charles Taylor and others have convincingly argued, language has a 
constitutive function as well as a descriptive or representational one, then the 
words we use and the common ways we talk about what we do have a great deal 
to do with who we are and how we act towards others.  Words, in this view, do 
not merely label things; they maintain and modify the kinds of common 
understandings that set up our possibilities for action in any particular situation.  
Words not only reflect, but shape what is real to us; they also shape us … (1999, 
p. 16).   
A careful examination of word use in this context goes beyond word-smithing and is 
important as it provides a critique of our “habits of language” and how and what 
language choices say about the organization’s underlying values.   
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Review and Feedback 
 
Bearing in mind these principles the committee then had to apply those questions as part 
of a process of review.  The committee’s process for review has evolved from a 
“detailed” review to what we describe as a “principled” review, as discussed in more 
detail below.  The last step, at the conclusion of the committee’s review, is to formulate 
an extensive report to send back to the policy’s authors setting out the committee’s 
concerns (if any) and related recommendations, along with an evaluation form that 
invites the recipient to provide feedback to the committee on its processes and 
recommendations.  The format that we have used to convey our advice back to the 
policy-makers has varied across the years, changes resulting from our internal review of 
the effectiveness of our modes of feedback and also as a result of feedback from those 
who have received the results of the ethics committee’s reviews of policies.   
Our initial process for the first two years involved a very detailed word-by-word, 
line-by-line, section-by-section review of the policy applying the questions or 
considerations outlined above (detailed review).  This process was problematic on a 
number of fronts.  First, one of the key challenges for ethics committees is to ensure that 
reviews and reports are prepared and delivered in a timely manner.  Ells notes that 
lengthy delays may damage the credibility of the service and diminish the likelihood that 
the concerns and recommendations will be addressed in light of the pressures to get a 
policy finalised (2006).  This detailed review process, combined with the relative 
infrequency of the committee’s meetings (monthly), meant that for some policies there 
was a considerable, as much as three months delay, before the report was finalised.  This 
was clearly unacceptable for the ethics committee and for policy-developers.  Second, 
this process resulted in very lengthy and detailed recommendations for change and our 
concerns about this outcome are discussed in more detail below.  Third, it also created a 
dilemma for members about exactly where the line should be drawn between ethical 
review (including effectiveness as it touches upon the institution’s ethical responsibilities 
and word use as it explicates values) and pure effectiveness review, for example, word-
smithing.   As a committee we became convinced that the latter was not our 
responsibility, however, especially in the early days of the committee’s operation, we 
recognize that we at times crossed that line which squandered time, shifted our focus and 
diluted the emphasis on ethics.   
Initially, we sent the person(s) responsible for the policy a list of recommended 
changes with suggestions for issues they should reflect on or solutions.  In this format 
our feedback, not surprisingly, was not always received well.  In addition, after several 
months we concluded that we, as a committee, were failing to address the educational 
aspect of our mandate in that we were not sufficiently educating the policy-makers as to 
the ethical rationale that underlay our recommendations.  After this, feedback was 
presented in a tabular format: one column identifying the recommended changes and the 
second column explaining the ethical rationale that underlay the recommendation.  This 
was more satisfactory from an educative perspective and feedback from policy-makers 
was more positive on this front.   
Interestingly, providing a rationale for each item of feedback had the additional 
benefit of illustrating for the committee that we were going beyond the appropriate 
scope of review for the committee.  A detailed review (as discussed above) in 
conjunction with an explanation of the ethical rationale resulted in very long reviews.  
This was not helpful and placed the perceived value of the ethics process in question as it 
may create a sense that ethics is an obstacle as opposed to a central part of good 
organizational process.  Although policy-makers appreciated the explanations of the 
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ethical rationale underlying the feedback, there remained some reservations about its 
quantity.   
Recently we shifted the nature of the reviews conducted by the committee from 
detailed to what we would term principled reviews.  A principled review does not involve 
a line-by-line analysis but rather focuses discussions at a global level on the ethical 
concerns in issue in the policy.  In our somewhat limited experience so far this has 
resulted in a far more efficient discussion of the policy, streamlined the feedback to 
policy-makers, for committee members resulted in a more satisfying engagement with the 
issues and has been received more positively by policy writers.  The current process of 
principled review neatly rolls up within itself an explanation of the 
questions/concerns/feedback with the ethical rationale, yet at the same time avoids the 
prescriptiveness or overly detailed nature of previous forms of communication.        
 
Conclusion 
 
Our experience is that there are a number of challenges associated with the transition 
from clinical ethics to organizational ethics, especially in the realm of policy review.  
Operational challenges required the ethics committee to develop strategies, such as 
targeted education and lobbying, to overcome embedded institutional resistance to 
change.  The committee was also faced with the challenge of moving organizational 
ethics from a theoretical construct to an operational reality.  This required consideration 
of the principles of organizational ethics in healthcare organizations and how these could 
be instantiated in the functions and operations of the ethics committee and the IWK 
more generally.  It also required the ethics committee to reflect on its own practices to 
ensure that it can provide useful and reflective comments and recommendations, in a 
timely manner, that fulfils its educational mandate and, most critically, that contributes to 
the development of an ethical organization, in part, vis-à-vis its policies.   
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